Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU890
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,384
Award facts
- Contract value 100% obligated
- $11,383.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL in pen form with a ceiling value of $11,383.65. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 19, 2025. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal pharmaceutical contracts with DLA, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The award of Zepbound reflects the company's role in providing diabetes and metabolic disorder medications to support Defense Health Agency and broader military healthcare programs. As a non-set-aside competitive award, this delivery order demonstrates the contractor's continued capability to meet federal procurement requirements for specialized pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26FU890?
SPE2DR26FU890 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FU890 worth?
The government has obligated $11,384 on SPE2DR26FU890.
Is contract SPE2DR26FU890 an order under another contract?
Yes. SPE2DR26FU890 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU890 competed?
The extent of competition for SPE2DR26FU890 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award